Dart Technical Overview

HOMER-1: The Clinical Machine

Author(s): Veeraj Mehta, Co-Founder at Dart

Abstract

In 1941, American factories retooled overnight - converting automobile assembly lines into aircraft production lines, scaling output not by hiring proportionally more workers, but by fundamentally redesigning how work got done. Healthcare faces an analogous inflection point. Chronic disease prevalence is accelerating, cancer diagnoses are projected to surge, and an aging population is compounding demand against a workforce that is already stretched beyond capacity. No system will hire its way through what's coming. DART exists to give them the machinery & support to retool before the wave hits.

The deployment of artificial intelligence in clinical settings has been constrained by a persistent structural problem: every new use case requires its own engineering cycle, its own clinical validation effort, and its own dedicated resources - producing siloed solutions that share no knowledge, compound no learning, and scale only through linear investment. The result is an industry where the cost and complexity of deploying clinical intelligence has kept it out of reach for all but the largest and most well-resourced health systems, and even then, only for a narrow set of applications.

This paper introduces HOMER-1, a stateful clinical reasoning runtime that fundamentally restructures how clinical intelligence is developed, validated, and delivered. Rather than executing pre-built logic against clinical data, HOMER-1 constructs decision logic, tools, and predictive models from natural language clinical intent - then validates, executes, and refines them through a governed sequence of five operational states: Factory, Plan, Analyze, Simulate, and Output.

HOMER-1 inverts the traditional economics of clinical AI deployment - where costs are linear, outputs are unverifiable, and knowledge is lost between engagements - into a model where marginal cost decreases and institutional intelligence appreciates with use.

I. A Different Kind of Problem Requires a Different Kind of Machine

Modern healthcare doesn't have a data problem. It has an action problem.

Health systems generate staggering volumes of clinical information every hour - vitals streaming from telemetry, labs populating in real time, imaging studies queued and completed, clinical notes dictated and signed, medications ordered and reconciled. The infrastructure to capture this data has matured significantly over the past two decades. The infrastructure to reason over it has not.

Today, when a health system wants to answer a question like "Which of our heart failure patients are undertreated on guideline-directed medical therapy, and what should we do about it?" - the reality of what happens next is staggering in its inefficiency.

First, a clinical champion defines the criteria. An analyst writes the query. A data scientist validates the logic. A project manager coordinates the rollout. That process alone takes months and costs six or seven figures.

But even after all of that work, the output is just a list. A list of potentially undertreated patients with no clinical reasoning attached.

Now a cardiologist has to review each patient individually - pulling up the chart, cross-referencing medications against current guidelines, evaluating renal function and contraindications, considering the patient's trajectory and prior titration attempts, and arriving at a clinical judgment. At ten to fifteen minutes per chart, a population of 500 patients represents over 80 hours of physician time - time that doesn't exist in any cardiology department's schedule. The patients who need optimization wait. Many never receive it.

With HOMER-1, that same question produces an entirely different outcome. The engine identifies the undertreated cohort, reasons through each patient's clinical context against current guidelines, surfaces its rationale, flags contraindications and edge cases, and delivers a prioritized, decision-ready output - complete with patient-specific reasoning that a cardiologist can review and act on in under two minutes per case. The physician's role shifts from doing the analytical work to validating the conclusion and making the call. The 80 hours collapses. The patients get optimized.

And when the same health system asks, "Now do the same thing for rheumatology" - HOMER-1 doesn't restart from scratch. It builds on what it's already learned.

This is the fundamental constraint DART set out to break.

This paper describes how HOMER-1 works, what it makes possible, and why its architecture represents a structural shift in how clinical intelligence is developed and deployed.

II. What HOMER-1 Is

HOMER-1, created & owned by DART, is a novel stateful clinical reasoning runtime - a purpose-built execution environment where complex clinical problems are decomposed, reasoned through, and solved across sustained operational sequences.

The word stateful is important. Most AI systems in healthcare are stateless: they receive an input, produce an output, and forget. HOMER-1 remembers & learns. It accumulates context at runtime & through feedback. It builds tools it will use again. It develops institutional knowledge that compounds over weeks and months, stored in persistent, customer-specific knowledge environments that grow more valuable with every task completed.

The word runtime is equally important. HOMER-1 is not a model. It is not a chatbot with a medical vocabulary. It is an environment - a governed operating system for clinical reasoning where specialized processes collaborate, generate code, construct analytical instruments, validate findings, and produce outputs that meet clinical-grade standards of transparency and reproducibility.

At its foundation, HOMER-1 operates on a cycle derived from the scientific method: observe the data, form hypotheses, design tests, validate results, and refine understanding. This cycle is not metaphorical. It is the literal operational loop that governs how HOMER-1 processes every task it receives.

III. The Five Operational States

Every task that enters HOMER-1 moves through a governed sequence of operational states. These states are not optional phases or loose guidelines - they are the architectural backbone of the system, managed by HOMER-1's orchestration layer, which determines when to advance, when to revisit, and when a task has met its completion criteria. At any point, the human may intervene to stop, adjust, or publish 

State 1: Factory

When HOMER-1 receives a clinical task for the first time - whether it's optimizing GDMT adherence across a patient population, constructing a discharge readiness assessment, or analyzing antimicrobial prescribing patterns - it enters Factory state.

In Factory, HOMER-1 operates continuously against a defined goal. During this phase, the engine:

• Constructs purpose-built tools for the task at hand. These are not abstract capabilities - they are concrete, validated instruments: clinical calculators, scoring algorithms, data transformation routines, statistical models, predictive classifiers, and custom analytical functions. HOMER-1 generates them as executable code, tests them against expected outputs, and persists them for future use. We call this capability Generative Toolchain Assembly - the system builds its own toolkit, specific to the problem, every time.
  
  
  

• Creates rules and contextual frameworks that encode the clinical logic required for the task. If the task involves heart failure management, Factory state produces the specific criteria, thresholds, escalation logic, and exception handling that the downstream states will execute against. These rules are derived from clinical guidelines, local organization policies, and human-specified parameters of the use case.
  
  
  

• Validates everything it builds. No tool, rule, or contextual framework exits Factory state without passing validation checkpoints. HOMER-1 tests its own constructions against known cases and edge conditions before promoting them. At completion, Factory collects human feedback and can run again.

Factory state is where HOMER-1's generative engineering capability is most visible. The engine can produce the equivalent volume and specificity of work that a large traditional engineering team would deliver over weeks or months - and it does so within a controlled environment where every artifact is versioned, logged, and reproducible. Factory runs till the goal is achieved, the state is manually paused/ended, or up till 24 Hours. It can be restarted without limit. Factory can also be set to Continuous Learning which allows it to monitor, suggest, and mitigate errors while improving performance at scale.

State 2: Plan

Once the necessary tools and context exist, HOMER-1 transitions to Plan state. This is the system's strategic reasoning phase - where the task is decomposed into an optimized execution sequence. Planning is generated for each run or presented through a human-built template.

Plan state performs what we call Adaptive Trace Decomposition: the process of converting a high-level clinical objective into a structured decision trace - a sequenced map of every reasoning step, data requirement, validation checkpoint, branching condition, and output specification needed to complete the task.

But Plan does more than decompose. It also:

• Locates and inventories available tools - both those generated during Factory and those persisted from prior tasks. If a relevant tool already exists in the system's library, Plan identifies it and incorporates it into the execution trace rather than rebuilding from scratch.
  
  
  

• Identifies potential failure modes and data gaps before execution begins, allowing the system to route around missing information or flag it for human input.
  
  
  

• Optimizes the execution sequence for efficiency, parallelizing independent subtasks and sequencing dependent ones to minimize total processing time.

The output of Plan state is a complete, auditable blueprint for how the task will be executed - transparent enough that a clinical reviewer can inspect the logic before a single data point is processed.

State 3: Analyze

With a validated plan in hand, HOMER-1 enters the Analyze state - where the core clinical work happens.

Analyze state executes the decision trace produced by Plan, working through each step methodically: accessing data, applying tools, evaluating criteria, scoring, identifying patterns, and building toward conclusions.

Critically, Analyze state operates in what we call a Recursive Validation Loop - it doesn't simply run to completion and declare an answer. Instead, each analytical step is checked against expected parameters. When results fall outside expected bounds, the loop triggers re-evaluation: re-examining data inputs, testing alternative interpretations, and applying additional validation before proceeding. This loop continues until the analysis meets defined confidence and completeness thresholds.

Analyze state also leverages HOMER-1's Deterministic-Probabilistic Fusion capability - seamlessly integrating code-based logic with probabilistic inference. For example,  A single analytical sequence might apply hard deterministic functions to medication dosing thresholds while simultaneously running probabilistic models on patient trajectory and risk.

State 4: Simulate

Before any output is finalized, HOMER-1 enters Simulate state - an independent validation phase that operates as a counterweight to the analysis. Typically, large scale deployments would require thousands of clinical hours of input - not anymore.

Simulate state takes the findings from Analyze and stress-tests them: modeling alternative scenarios, projecting outcomes under different assumptions, and identifying edge cases or confounding factors that the primary analysis may not have fully accounted for. This is where HOMER-1's scientific method foundation is most apparent - the system doesn't just arrive at a conclusion, it actively tries to challenge it.

Simulation sends its findings back to the Analyze state to create a tight feedback loop and improve accuracy. Simulation outputs can be woven into the final deliverable, giving clinicians and decision-makers not just an answer, but a landscape of possibilities: "Here is what we found. Here is what would change if these assumptions shifted. Here is the confidence boundary."

This state is what separates HOMER-1 from systems that produce a single, take-it-or-leave-it prediction. HOMER-1's outputs reflect clinical variability rather than hiding it.

State 5: Output

The final state produces a structured, well-formed deliverable - whether that's a clinical report, a risk stratification, a set of patient-specific recommendations, a cohort analysis, an API payload, or an automated action trigger.

Output state is not a raw data dump. HOMER-1 composes its outputs with the same rigor it applies to analysis: findings are organized, contextualized, and presented with full reasoning transparency. Every conclusion is traceable back through the Simulate, Analyze, and Plan states that produced it. Every data point carries provenance. Every tool used is identified.

When HOMER-1's confidence thresholds are not met, or when the task requires clinical judgment that exceeds the system's scope, Output state performs a structured human handoff - surfacing findings, uncertainties, and recommended next steps to a human reviewer with complete reasoning context. HOMER-1 knows what it knows and, critically, knows what it doesn't.

IV. Compounded Learning: The Acceleration Curve

One of the most common misconceptions about generative clinical intelligence is that every task takes the same amount of effort. In traditional development, that's true - each new use case restarts the engineering cycle from scratch. HOMER-1 works differently.

The first time HOMER-1 encounters a new clinical domain or task type, it invests the most effort (tokens + time). Factory state constructs the necessary tools, rules, and contextual frameworks from the ground up. Plan state maps the execution logic for the first time. Analyze state works through the reasoning sequence without the benefit of prior validated patterns.

But every artifact HOMER-1 creates during that first task - every tool, every rule, every validated analytical routine, every contextual framework - is persisted in the customer's dedicated knowledge environment. This is what we call State Persistence: the system doesn't just solve problems, it learns how to solve them and retains that knowledge for future use.

The result is a characteristic acceleration curve:

[Figure 1: HOMER-1 Compounded Learning Curve]

The chart below illustrates task completion time across successive case executions within a clinical domain. The curve flattens as the system reaches its operational floor: the minimum time required to ingest data, execute validated logic, and produce a quality-assured output.

Task Completion Time

│

│  ■

│

│     ■

│

│        ■

│           ■

│              ■  

│                    ■   ■  ■  ■  ■  ■ ■  ■

└──────────────────────────────────────

 1  2   3   4   5   6 7  8   9  10 11 12   13 ...    N

                     Case Number

By the fifth or sixth case within a domain, HOMER-1 typically operates at or near its operational floor - executing the full state sequence (Plan → Analyze → Simulate → Output) in minutes rather than hours. Factory state is invoked only when genuinely new capabilities are required, not on every run.

This compounding dynamic has a direct economic implication: the marginal cost of each additional case decreases over time, while the quality and speed of output increases. It is the inverse of traditional consulting and engineering models, where costs are linear or increasing and institutional knowledge is lost at the end of every engagement.

Critically, this compounding is domain-aware. Knowledge accumulated while optimizing GDMT adherence accelerates adjacent cardiovascular use cases. Patterns learned in one clinical specialty inform analogous reasoning in another. The system doesn't just get faster at repeating the same task - it gets faster at learning new ones. This is especially critical for organizations deploying AI across a spectrum of use cases, as sociotechnical elements are the highest drivers of cost & time.

V. What HOMER-1 Can Build: Capability Snapshots

The generative nature of HOMER-1 is best understood through concrete examples of what the system produces during its operational states. These are not theoretical capabilities - they are artifacts the engine constructs, validates, and persists as reusable instruments.

High-Performance Predictive Models - Built in 90 Seconds HOMER-1 can generate production-grade machine learning classifiers - logistic regression, gradient-boosted trees, ensemble methods - with clinically validated AUROC performance in as little as 90 seconds. The engine handles feature selection, training, cross-validation, and threshold optimization autonomously. These models are calibrated against the institution's own historical outcomes, not generic population data. Once validated, these models are persisted and can be invoked on-demand for real-time patient scoring across the entire population. What traditionally requires a data science team working for weeks is generated, tested, and deployed as a callable tool within the runtime.

Custom Clinical Calculators & Scoring Applications When a task requires a scoring algorithm that doesn't exist as a standard instrument - or when institutional policy modifies a standard score - HOMER-1 builds it. Custom acuity scores, composite risk indices, weighted compliance metrics, adjusted outcome benchmarks. Each calculator is generated as validated, executable logic with documented inputs, thresholds, and interpretation rules.

Automated Evidence Synthesizers For tasks that require reasoning across clinical literature, guidelines, and institutional protocols simultaneously, HOMER-1 constructs evidence synthesis routines that cross-reference multiple knowledge sources, identify conflicts or gaps, and produce structured summaries ranked by evidence strength and institutional relevance.

• More

Each of these capabilities is produced within HOMER-1's governed runtime, validated before deployment, and stored in the customer's knowledge environment for immediate reuse. They are not separate products or add-on modules. They are things HOMER-1 builds in the course of doing its work - and they accumulate over time, forming an ever-expanding library of institutional clinical intelligence.

VI. Persistent Intelligence: How HOMER-1 Learns and Compounds

Most clinical AI systems are amnesiac. They process a query, return a result, and retain nothing. The next query starts from zero.

HOMER-1 is architecturally different. Every task the system completes generates persistent artifacts - tools, rules, contextual frameworks, validated analytical routines, predictive models, and performance data - that are stored in customer-specific knowledge environments. These environments are isolated, persistent data stores scoped to each organization and use case, ensuring that institutional knowledge accumulates securely and never crosses organizational boundaries.

This persistence mechanism - State Persistence - is the source of HOMER-1's compounding advantage, and the engine behind the acceleration curve described in Section IV.

When HOMER-1 optimizes GDMT adherence for a health system's cardiology population, it doesn't just produce a report and move on. It retains the tools it built, the rules it encoded, the predictive models it generated, the validation patterns it developed, and the contextual understanding it gained. When the same health system later asks HOMER-1 to address discharge planning, the engine doesn't start from scratch - it draws on relevant accumulated knowledge, adapting tools and context from prior work where applicable.

Over time, this creates an institutional intelligence layer - a growing body of validated clinical logic, specialized tools, and organizational knowledge that becomes more valuable with each task completed. It is the difference between hiring a consultant who leaves when the engagement ends and building an internal capability that improves every quarter.

The persistent architecture also means HOMER-1 maintains rich Contextual Memory across multiple scopes simultaneously:

• Patient-Level Memory: Longitudinal tracking of individual patient trajectories, treatment responses, and risk evolution

• Cohort-Level Memory: Population patterns, outcome distributions, and comparative effectiveness insights

• Organizational Memory: Institutional protocols, formulary specifics, staffing patterns, and operational constraints

• Domain Memory: Specialty-specific clinical knowledge, guideline interpretations, and evidence hierarchies

This layered memory system - the Contextual Memory Architecture - enables HOMER-1 to reason with the kind of contextual depth that has historically required a senior clinician's years of institutional experience.

VII. Governed Execution: Safety by Architecture

Everything described above - every state transition, every tool built, every analysis run, every simulation executed - happens within HOMER-1's governed execution environment.

This is not an afterthought or a compliance layer. Governance is a foundational design principle baked into HOMER-1's architecture from the ground up.

HOMER-1 operates within a dedicated, controlled runtime - generating and managing all artifacts (code, tools, data transformations, intermediate results, predictive models, and final outputs) within strict environmental boundaries. Customer-specific knowledge environments are isolated at the data layer, ensuring complete separation between organizations. No process within HOMER-1 can reach beyond its defined boundaries, and all interactions with external clinical systems are mediated through controlled, auditable integration points.

This means:

• HOMER-1 never directly modifies clinical source systems. All interactions with EMRs, data warehouses, and registries occur through controlled integration interfaces with full audit logging.

• HOMER-1 never prescribes, orders, or takes autonomous clinical action. It reasons, analyzes, recommends, and reports - but last-mile sign off remains in clinicians hands.

• Every artifact is versioned and reproducible. If a question arises about why HOMER-1 reached a particular conclusion six months ago, the complete reasoning chain - including the tools used, the data accessed, and the intermediate steps taken - can be reconstructed and inspected.

The governed execution model extends to HOMER-1's internal operations as well. Each operational state has defined entry and exit criteria. State transitions are logged. Tool generation is validated before deployment. Predictive models are tested against performance thresholds before being made available. The system enforces rigor on itself at every level.

VIII. Ingestion: Meeting Healthcare Data Where It Lives

HOMER-1 accepts clinical data across the full spectrum of healthcare information standards and modalities:

Interoperability: FHIR R4, HL7v2, direct API integration, device-to-device streaming, and flat file ingestion

Multimodal Processing: Structured data (labs, vitals, medications, diagnoses), unstructured text (clinical notes, discharge summaries, operative reports), medical imaging, waveform telemetry, and scanned documents

Real-Time Connectivity: Near real-time sync with source systems - EMRs, data warehouses, clinical registries, and operational databases - ensuring that HOMER-1 reasons over current data, not stale extracts

The ingestion layer normalizes and contextualizes incoming data before it enters the reasoning pipeline, abstracting away the heterogeneity of source systems so that downstream processing operates on a unified clinical data model.

IX. What HOMER-1 Powers: DART Products

HOMER-1's generative architecture enables DART to deliver purpose-built clinical intelligence products at a speed and cost that would be impossible under traditional development models.

Dart Strategist

Strategist is an AI Clinical Data Analyst powered by HOMER-1 that connects to existing data infrastructure & answers complex queries in near real-time.

Clinical and operational teams interact with Strategist through natural language - no SQL/Python, no BI tools, no technical skills required. Strategist translates queries into full analytical workflows, executed through HOMER-1's state machine, and returns structured reports, visualizations, and insights in minutes not days.

High-value use cases include quality analysis, ASP surveillance, population health management, data driven service line leadership, HCAHPs monitoring, and more.

Due to HOMER-1, Strategist requires no data model. Instead, Strategist is able to Join & build standardizations on its own, in real time.

Strategist, powered by HOMER-1, is a true personal analyst. If a user asks for a prediction, Strategist can gather data, generate a model, and validate it. In <5 minutes, an organization can have access to a high AUROC ML model. If a user asks for a dashboard across disparate systems that have no standard data model, Strategist can create Joins in real time & create visualizations. + So much more.

Dart Drivetrain

Drivetrain is a clinical workload engine that applies HOMER-1's full reasoning capability to patient-level clinical operations.

Each Drivetrain instance is configured for a specific use case - GDMT optimization, discharge planning, antimicrobial stewardship, triage, care gap closure, or any other clinical workflow that can be described in terms of data inputs, decision logic, and desired outcomes. HOMER-1 builds the necessary tools, rules, and analytical frameworks during its Build state, and subsequent executions run through the full state sequence at scale.

Drivetrain runs through each state autonomously to build & tackle complex clinical workloads. ~0 engineering efforts, minimal SME input, and high throughput.

X. Why HOMER-1 Changes the Economics

The traditional model for deploying clinical AI follows a pattern that is expensive, slow, and non-compounding:

A vendor or internal team scopes the problem. Engineers build a custom pipeline. Data scientists develop and train models. Clinical subject matter experts validate logic over hundreds of hours. The solution is deployed after 6–18 months at a cost that typically starts in the seven figures. And when the next use case arrives, the cycle restarts - because the first solution was built as a point system that shares nothing with whatever comes next.

HOMER-1 replaces this model with generative engineering - the system develops its own clinical logic, tools, and validation frameworks as a function of the runtime itself.

The compounding row is the one that matters most over time. Every task HOMER-1 completes makes the next task faster, more accurate, and less expensive. Knowledge doesn't leave when a consulting engagement ends or an engineer moves on - it persists in the platform, growing more valuable with every use case deployed. A lower cost per use case doesn't just save money — it unlocks an entire class of clinical applications that never clear ROI thresholds with existing vendors. See how much more we can tackle:

Value Axis

│

│                                                          ██

│                                                       ██ ██

│                                                    ██ ██ ██

│                                                 ██ ██ ██ ██

│       - - - - - -Other Vendors ---- - -    ██─██─██─██─██

│                                           ██ ██ ██ ██ ██ ██

│                                        ██ ██ ██ ██ ██ ██ ██

│                                     ██ ██ ██ ██ ██ ██ ██ ██

│                                  ██ ██ ██ ██ ██ ██ ██ ██ ██

│                               ██ ██ ██ ██ ██ ██ ██ ██ ██ ██

│  - - - - - -DART --- - - - ██-██-██-██-██-██-██-██-██-██-██-

│  └─────────────────────────────────────────────

Use Cases  

██  Only viable with DART

██  Viable with any vendor

*Gallifant, Jack, et al. “Beyond the Algorithm: A Field Guide to Deploying AI Agents in Clinical Practice.” ArXiv.org, 2025, arxiv.org/abs/2509.26153.

XI. Observability: Every Decision, Explained

Clinical AI that cannot explain itself is clinical AI that cannot be trusted. HOMER-1 was designed from the ground up for complete operational transparency.

The observability layer provides:

• Reasoning Traces: Step-by-step documentation of how every conclusion was reached, from initial data access through final output

• State Transition Logs: Full records of when and why the system moved between Build, Plan, Analyze, Simulate, and Output states

• Tool Provenance: Identification of every tool used, when it was built, how it was validated, and what role it played in the analysis

• Data Lineage: Complete tracking of every data element that influenced a decision - where it came from, how it was transformed, and how it was weighted

• Confidence Reporting: Transparent communication of certainty levels, assumption sensitivity, and areas where human judgment is recommended

This is not a feature bolted on for compliance. It is the architecture. Every artifact HOMER-1 produces carries its full provenance chain, making post-hoc audit, regulatory review, and clinical quality assessment straightforward and complete.

XII. Security, Isolation & Compliance

HOMER-1 operates within a fully governed execution environment with security and compliance designed for enterprise healthcare:

• Tenant Isolation: Customer-specific knowledge environments are architecturally separated at the data layer

• Environmental Governance: All reasoning, tool generation, and analysis occur within controlled runtime boundaries

• Access Controls: Role-based permissions, data-level authorization, and organizational boundary enforcement

• Audit Completeness: Every data access, reasoning step, tool invocation, and system action is logged

• Regulatory Alignment: Architecture designed for HIPAA, HITRUST, and SOC 2 compliance frameworks

XIII. Conclusion

The healthcare industry has spent two decades building the infrastructure to capture clinical data. The next decade will be defined by the infrastructure to reason over it.

HOMER-1 is that infrastructure - a clinical machine that constructs its own tools, accumulates institutional knowledge, navigates clinical complexity through governed operational states, and delivers validated intelligence at a speed and cost that fundamentally changes the economics of clinical AI.

It is not a model. It is not a dashboard. It is not a point solution.

It is a machine that builds clinical intelligence - and gets better every time it runs.

About DART Health

DART is a clinical intelligence company building the reasoning infrastructure for Clinical AI Workloads. Our platform, powered by HOMER-1, enables healthcare to deploy sophisticated clinical intelligence capabilities in weeks rather than years.

For more information, visit darthealth.ai or contact veeraj@darthealth.ai.

© 2026 DART Health. All rights reserved. This document contains proprietary and confidential information.